{{Rsnum
|rsid=12047808
|Gene=C1orf125
|Chromosome=1
|position=179500179
|Orientation=plus
|GMAF=0.1538
|Gene_s=AXDND1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 79.6 | 18.6 | 1.8
| HCB | 66.4 | 29.9 | 3.6
| JPT | 87.6 | 12.4 | 0.0
| YRI | 44.2 | 43.5 | 12.2
| ASW | 64.9 | 33.3 | 1.8
| CHB | 66.4 | 29.9 | 3.6
| CHD | 67.0 | 30.3 | 2.8
| GIH | 97.0 | 3.0 | 0.0
| LWK | 53.6 | 37.3 | 9.1
| MEX | 84.5 | 13.8 | 1.7
| MKK | 51.9 | 38.5 | 9.6
| TSI | 83.3 | 15.7 | 1.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (age of onset)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000006
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs12047808
|Name_s=
|Gene_s=C1orf125
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 978 cases, 883 controls; Replication Sample Size: NR); (Region: 1q25.2; Reported Gene(s): C1orf125; Risk Allele: rs12047808-?); (p-value= 0.000006).This variant is associated with Multiple sclerosis (age of onset).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740722
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs12047808
|overall_frequency_n=17
|overall_frequency_d=122
|overall_frequency=0.139344
|n_genomes=16
|n_genomes_annotated=0
|n_haplomes=18
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}